NEUVIVO
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Oct 2025)
What this means for you
This application is over — abandoned 20 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97020234
- Mark type
- Design + words
- Filed
- 09 Sept 2021
- Published for opposition
- 19 Jul 2022
- Abandoned
- 20 Oct 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: medicines and pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (als); medicines and pharmaceutical preparations for the treatment of neurodegenerative diseases; medicines and pharmaceutical preparations for the treatment of central nervous system and peripheral nervous system diseases and disorders; medicines and pharmaceutical preparations for the treatment of viral diseases
- Class 042 — Scientific and technological services: scientific research for medical purposes in the field of amyotrophic lateral sclerosis (als), neurodegenerative diseases, central nervous system and peripheral nervous system diseases and disorders, and viral diseases
Owner
- Neuvivo, Inc., Palo Alto, CA, US
- Neuvivo, Inc., Los Altos, CA, US
Prosecution history
- 21 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2025 — SOU EXTENSION 5 GRANTED
- 09 Mar 2025 — SOU EXTENSION 5 FILED
- 07 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Aug 2024 — SOU EXTENSION 4 GRANTED
- 21 Aug 2024 — SOU EXTENSION 4 FILED
- 21 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 14 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2024 — SOU EXTENSION 3 GRANTED
- 13 Mar 2024 — SOU EXTENSION 3 FILED
- 13 Mar 2024 — SOU TEAS EXTENSION RECEIVED